Exploration of COVID-19 associated bradycardia using heart rate variability analysis in a case-control study of ARDS patients.

This study confirmed that C-ARDS was associated with marked bradycardia and severe ANS impairment, suggesting a sympathovagal imbalance with vagal overtone. Poor outcomes appeared to be more related to sympathetic rather than parasympathetic hyperactivation.